| Date | Name | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Wed, 19 Aug 2026 | Stewart Richard Alistair | director | S-Sale | 20,626 | $175.18K |
| Holder | Shares | % out | Change |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7,614,836 | 7.4% | — |
| TPG GP A, LLC | 6,877,580 | 6.7% | — |
| venBio Partners LLC | 5,914,720 | 5.7% | — |
| Logos Global Management LP | 5,425,000 | 5.3% | — |
| BlackRock, Inc. | 5,272,017 | 5.1% | +4,832,657 |
| FRANKLIN RESOURCES INC | 4,953,220 | 4.8% | +584,027 |
| Paradigm Biocapital Advisors LP | 4,951,856 | 4.8% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,140,812 | 4.0% | +1,936,098 |
| Propel Bio Management, LLC | 4,034,018 | 3.9% | +247,593 |
| MARSHALL WACE, LLP | 3,770,313 | 3.7% | +2,751,032 |
| STATE STREET CORP | 2,945,526 | 2.9% | +2,691,069 |
| Venrock Adviser, LLC | 2,751,032 | 2.7% | — |
| Jupiter Topco LLC | 2,751,032 | 2.7% | — |
| Vivo Capital, LLC | 2,751,032 | 2.7% | — |
| EVENTIDE ASSET MANAGEMENT, LLC | 2,220,000 | 2.2% | — |